Cargando…

Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development

[Image: see text] Preferential crystallization is a cost efficient method to provide pure enantiomers from a racemic mixture of a conglomerate forming system. Exploiting small amounts of pure crystals of both enantiomers, several batch or continuous processes were developed, capable of providing bot...

Descripción completa

Detalles Bibliográficos
Autores principales: Temmel, Erik, Eicke, Matthias J., Cascella, Francesca, Seidel-Morgenstern, Andreas, Lorenz, Heike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493326/
https://www.ncbi.nlm.nih.gov/pubmed/32952448
http://dx.doi.org/10.1021/acs.cgd.8b01660
_version_ 1783582544851107840
author Temmel, Erik
Eicke, Matthias J.
Cascella, Francesca
Seidel-Morgenstern, Andreas
Lorenz, Heike
author_facet Temmel, Erik
Eicke, Matthias J.
Cascella, Francesca
Seidel-Morgenstern, Andreas
Lorenz, Heike
author_sort Temmel, Erik
collection PubMed
description [Image: see text] Preferential crystallization is a cost efficient method to provide pure enantiomers from a racemic mixture of a conglomerate forming system. Exploiting small amounts of pure crystals of both enantiomers, several batch or continuous processes were developed, capable of providing both species. However, an intermediate production step has to be used when pure enantiomers are not available. In such cases, partially selective synthesis, chromatography, or crystallization processes utilizing chiral auxiliaries have to be used to provide the initial seed material. Recently, it was shown that a coupled Preferential Crystallization-selective Dissolution process (CPCD) in two coupled crystallizers can be applied if at least one pure enantiomer is available to produce both antipodes within one batch. The corresponding process is carried out in one reactor (crystallization tank) by seeding a racemic supersaturated solution with the available enantiomer at a certain temperature. The second reactor (dissolution tank) contains a saturated racemic suspension at a higher temperature. Both reactors are coupled via the fluid phase, allowing for a selective dissolution of the preferentially crystallizing enantiomer from the solid racemic feed provided in the dissolution vessel. The dissolution and crystallization processes continue until the solid racemic material is completely resolved and becomes enantiopure. At this point, both enantiomers can be harvested in their pure crystalline form. For a specific pharmaceutically relevant case study, a rational process design and the applied empirical optimization procedure will be described. The achieved productivities after optimization show the great potential of this approach also for industrial applications. Also, a strategy to control this process based on inline turbidity measurement will be presented.
format Online
Article
Text
id pubmed-7493326
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-74933262020-09-16 Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development Temmel, Erik Eicke, Matthias J. Cascella, Francesca Seidel-Morgenstern, Andreas Lorenz, Heike Cryst Growth Des [Image: see text] Preferential crystallization is a cost efficient method to provide pure enantiomers from a racemic mixture of a conglomerate forming system. Exploiting small amounts of pure crystals of both enantiomers, several batch or continuous processes were developed, capable of providing both species. However, an intermediate production step has to be used when pure enantiomers are not available. In such cases, partially selective synthesis, chromatography, or crystallization processes utilizing chiral auxiliaries have to be used to provide the initial seed material. Recently, it was shown that a coupled Preferential Crystallization-selective Dissolution process (CPCD) in two coupled crystallizers can be applied if at least one pure enantiomer is available to produce both antipodes within one batch. The corresponding process is carried out in one reactor (crystallization tank) by seeding a racemic supersaturated solution with the available enantiomer at a certain temperature. The second reactor (dissolution tank) contains a saturated racemic suspension at a higher temperature. Both reactors are coupled via the fluid phase, allowing for a selective dissolution of the preferentially crystallizing enantiomer from the solid racemic feed provided in the dissolution vessel. The dissolution and crystallization processes continue until the solid racemic material is completely resolved and becomes enantiopure. At this point, both enantiomers can be harvested in their pure crystalline form. For a specific pharmaceutically relevant case study, a rational process design and the applied empirical optimization procedure will be described. The achieved productivities after optimization show the great potential of this approach also for industrial applications. Also, a strategy to control this process based on inline turbidity measurement will be presented. American Chemical Society 2019-05-01 2019-06-05 /pmc/articles/PMC7493326/ /pubmed/32952448 http://dx.doi.org/10.1021/acs.cgd.8b01660 Text en Copyright © 2019 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Temmel, Erik
Eicke, Matthias J.
Cascella, Francesca
Seidel-Morgenstern, Andreas
Lorenz, Heike
Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development
title Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development
title_full Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development
title_fullStr Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development
title_full_unstemmed Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development
title_short Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development
title_sort resolution of racemic guaifenesin applying a coupled preferential crystallization-selective dissolution process: rational process development
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493326/
https://www.ncbi.nlm.nih.gov/pubmed/32952448
http://dx.doi.org/10.1021/acs.cgd.8b01660
work_keys_str_mv AT temmelerik resolutionofracemicguaifenesinapplyingacoupledpreferentialcrystallizationselectivedissolutionprocessrationalprocessdevelopment
AT eickematthiasj resolutionofracemicguaifenesinapplyingacoupledpreferentialcrystallizationselectivedissolutionprocessrationalprocessdevelopment
AT cascellafrancesca resolutionofracemicguaifenesinapplyingacoupledpreferentialcrystallizationselectivedissolutionprocessrationalprocessdevelopment
AT seidelmorgensternandreas resolutionofracemicguaifenesinapplyingacoupledpreferentialcrystallizationselectivedissolutionprocessrationalprocessdevelopment
AT lorenzheike resolutionofracemicguaifenesinapplyingacoupledpreferentialcrystallizationselectivedissolutionprocessrationalprocessdevelopment